Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | F109Sfs*14 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | TP53 F109Sfs*14 indicates a shift in the reading frame starting at amino acid 109 and terminating 14 residues downstream causing a premature truncation of the 393 amino acid Tp53 protein (UniProt.org). F109Sfs*14 has not been biochemically characterized however, due to the effects of truncation mutations downstream of F109 (PMID: 31081129, PMID: 34045312), is predicted to lead to a loss of Tp53 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon4 TP53 F109Sfs*14 TP53 mutant TP53 inact mut TP53 F109Sfs*14 |
Transcript | NM_000546.6 |
gDNA | chr17:g.7676045delA |
cDNA | c.326delT |
Protein | p.F109Sfs*14 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000546.5 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_001126114 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_001126113.2 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7676045delA | c.326delT | p.F109Sfs*14 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|